المؤلفون: Ramanan, R, Lim, ABM, Tan, JLC, Barmanray, RD, Mason, K, Collins, J, Hillman, M, Szer, J, Bajel, A, Ritchie, D

مصطلحات الفهرس: Journal Article

URL: http://hdl.handle.net/11343/307603

المؤلفون: Ramanan R; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia., Lim ABM; Department of Clinical Haematology and Olivia Newton John Cancer Research Institute, Austin Health, Melbourne, Victoria, Australia., Tan JLC; Department of Haematology, Alfred Health, Melbourne, Victoria, Australia., Barmanray RD; Department of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia., Mason K; Department of Clinical Haematology and Olivia Newton John Cancer Research Institute, Austin Health, Melbourne, Victoria, Australia., Collins J; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia., Hillman M; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia., Szer J; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia., Bajel A; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Ritchie D; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia.

المصدر: Internal medicine journal [Intern Med J] 2023 Jun; Vol. 53 (6), pp. 951-960. Date of Electronic Publication: 2022 Sep 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 101092952 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1445-5994 (Electronic) Linking ISSN: 14440903 NLM ISO Abbreviation: Intern Med J Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Graft vs Host Disease*/prevention & control , Graft vs Host Disease*/etiology, Humans ; Methotrexate/adverse effects ; Cyclosporine/adverse effects ; Retrospective Studies ; Drug Tapering

المؤلفون: Rees MJ; Department of Clinical Haematology, Austin Health, Melbourne, VIC, Australia. Matthew.Rees@austin.org.au., Mollee P; Department of Haematology, Princess Alexandra Hospital, and School of Medicine, University of Queensland, Brisbane, QLD, Australia., Ng JY; Department of Haematology, Princess Alexandra Hospital, and School of Medicine, University of Queensland, Brisbane, QLD, Australia., Murton A; Department of Haematology, Royal Hobart Hospital, Hobart, TAS, Australia., Gonsalves JF; Department of Haematology, St Vincent's Hospital, Melbourne, VIC, Australia., Panigrahi A; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Beer H; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Loh J; Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VIC, Australia., Nguyen P; Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VIC, Australia., Hunt S; Department of Haematology, Eastern Health, Melbourne, VIC, Australia., Jina H; Department of Haematology, Eastern Health, Melbourne, VIC, Australia., Wayte R; Department of Clinical Haematology, Westmead Hospital, Sydney, NSW, Australia., Sutrave G; Department of Clinical Haematology, Westmead Hospital, Sydney, NSW, Australia., Tan J; Department of Haematology, University Hospital Geelong, Geelong, VIC, Australia., Abeyakoon C; Department of Haematology, University Hospital Geelong, Geelong, VIC, Australia., Chee A; Department of Haematology, Sir Charles Gairdner Hospital, Perth, WA, Australia., Augustson B; Department of Haematology, Sir Charles Gairdner Hospital, Perth, WA, Australia., Kalro A; Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia., Lee C; Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia., Agrawal S; Department of Haematology, Princes of Wales Hospital, Sydney, NSW, Australia., Churilov L; Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australia., Chua CC; Department of Clinical Haematology, Austin Health, Melbourne, VIC, Australia., Lim ABM; Department of Clinical Haematology, Austin Health, Melbourne, VIC, Australia., Zantomio D; Department of Clinical Haematology, Austin Health, Melbourne, VIC, Australia., Grigg A; Department of Clinical Haematology, Austin Health, Melbourne, VIC, Australia.

المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2021 Sep; Vol. 56 (9), pp. 2152-2159. Date of Electronic Publication: 2021 Apr 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Immune Reconstitution* , Multiple Myeloma*/drug therapy, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Autografts ; Bortezomib/therapeutic use ; Cyclophosphamide/therapeutic use ; Dexamethasone/therapeutic use ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Hematopoietic Stem Cell Mobilization ; Humans ; Melphalan/therapeutic use ; Retrospective Studies

المؤلفون: Tan JLC; Bone Marrow Transplant Service, Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia. joa.tan@alfred.org.au.; Department of Clinical Haematology and Bone Marrow Transplantation, The Alfred Hospital, Prahan, VIC, Australia. joa.tan@alfred.org.au., Wong E; Bone Marrow Transplant Service, Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Department of Clinical Haematology and Bone Marrow Transplant Service, The Austin Hospital, Heidelberg, VIC, Australia., Bajel A; Bone Marrow Transplant Service, Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia., Ramanan R; Bone Marrow Transplant Service, Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia., Lim ABM; Bone Marrow Transplant Service, Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Department of Clinical Haematology and Bone Marrow Transplant Service, The Austin Hospital, Heidelberg, VIC, Australia., Ritchie DS; Bone Marrow Transplant Service, Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.

المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2020 Sep; Vol. 55 (9), pp. 1857-1859. Date of Electronic Publication: 2020 Jan 21.

نوع المنشور: Letter

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease* , Hematopoietic Stem Cell Transplantation*/adverse effects , Mucositis*/etiology, Cyclosporine/adverse effects ; Humans ; Transplantation, Homologous

المؤلفون: Usmani SZ; Levine Cancer Institute/Atrium Health, Charlotte, NC, USA. Electronic address: saad.usmani@carolinashealthcare.org., Schjesvold F; Oslo Myeloma Center, Oslo University Hospital and KG Jebsen Center for B-Cell Malignancies, University of Oslo, Oslo, Norway., Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Spain., Karlin L; Centre Hospitalier Lyon-Sud, Pierre-Bénite, France., Cavo M; Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy., Rifkin RM; Rocky Mountain Cancer Centers, Denver, CO, USA., Yimer HA; Texas Oncology, Tyler, TX, USA., LeBlanc R; Centre Intégré Universitaire de Santé et de Services Sociaux de l'Est de L'Ile de Montréal, University of Montreal, Montreal, QC, Canada., Takezako N; Disaster Medical Center, Tokyo, Japan., McCroskey RD; Northwest Medical Specialties, PLLC, Puyallup, WA, USA., Lim ABM; Austin Health, Austin Hospital, Heidelberg, VIC, Australia., Suzuki K; Japanese Red Cross Medical Center, Tokyo, Japan., Kosugi H; Ogaki Municipal Hospital, Ogaki, Japan., Grigoriadis G; Monash Health, Melbourne, VIC, Australia., Avivi I; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel., Facon T; Hôpital Claude Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France., Jagannath S; Mount Sinai Hospital, New York, NY, USA., Lonial S; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Ghori RU; Merck & Co, Inc, Kenilworth, NJ, USA., Farooqui MZH; Merck & Co, Inc, Kenilworth, NJ, USA., Marinello P; Merck & Co, Inc, Kenilworth, NJ, USA., San-Miguel J; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Centro de Investigación Biomédica en Red de Cáncer, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.

مؤلفون مشاركون: KEYNOTE-185 Investigators

المصدر: The Lancet. Haematology [Lancet Haematol] 2019 Sep; Vol. 6 (9), pp. e448-e458. Date of Electronic Publication: 2019 Jul 18.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*administration & dosage , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Dexamethasone/*administration & dosage , Lenalidomide/*administration & dosage , Multiple Myeloma/*drug therapy, Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Dexamethasone/adverse effects ; Female ; Humans ; Lenalidomide/adverse effects ; Male ; Multiple Myeloma/mortality ; Multiple Myeloma/pathology ; Pneumonia/etiology ; Progression-Free Survival ; Proportional Hazards Models ; Survival Rate ; Treatment Outcome

المؤلفون: Lim ABM; Department of Clinical Haematology and BMT Service, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; The University of Melbourne, Melbourne, Victoria, Australia., Curley C; Department of Haematology and BMT, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Fong CY; Department of Clinical Haematology, The Alfred, Melbourne, Victoria, Australia., Bilmon I; Haematology Department, St Vincent's Hospital, Sydney, New South Wales, Australia.; Department of Haematology, Westmead Hospital, Sydney, New South Wales, Australia., Beligaswatte A; Clinical Haematology Bone Marrow Transplant Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia., Purtill D; Department of Haematology, Royal Perth Hospital, Perth, Western Australia, Australia., Getta B; Department of Haematology, Westmead Hospital, Sydney, New South Wales, Australia., Johnston AM; Institute of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Armytage T; Haematology Department, Royal North Shore Hospital, Sydney, New South Wales, Australia., Collins M; Centre for Biostatistics and Clinical Trials, Melbourne, Victoria, Australia., Mason K; Department of Clinical Haematology and BMT Service, The Royal Melbourne Hospital, Melbourne, Victoria, Australia., Fielding K; Department of Clinical Haematology and BMT Service, The Royal Melbourne Hospital, Melbourne, Victoria, Australia., Greenwood M; Haematology Department, Royal North Shore Hospital, Sydney, New South Wales, Australia., Gibson J; Institute of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.; The University of Sydney, Sydney, New South Wales, Australia., Hertzberg M; Department of Haematology, Westmead Hospital, Sydney, New South Wales, Australia., Wright M; Department of Haematology, Royal Perth Hospital, Perth, Western Australia, Australia., Lewis I; Clinical Haematology Bone Marrow Transplant Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia., Moore J; Haematology Department, St Vincent's Hospital, Sydney, New South Wales, Australia., Curtis D; Department of Clinical Haematology, The Alfred, Melbourne, Victoria, Australia., Szer J; Department of Clinical Haematology and BMT Service, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; The University of Melbourne, Melbourne, Victoria, Australia., Kennedy G; Department of Haematology and BMT, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Ritchie D; Department of Clinical Haematology and BMT Service, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; The University of Melbourne, Melbourne, Victoria, Australia.

المصدر: Internal medicine journal [Intern Med J] 2018 Mar; Vol. 48 (3), pp. 276-285.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 101092952 Publication Model: Print Cited Medium: Internet ISSN: 1445-5994 (Electronic) Linking ISSN: 14440903 NLM ISO Abbreviation: Intern Med J Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation/*mortality , Hematopoietic Stem Cell Transplantation/*trends , Leukemia, Myeloid, Acute/*mortality , Leukemia, Myeloid, Acute/*therapy, Adolescent ; Adult ; Aged ; Databases, Factual/trends ; Female ; Follow-Up Studies ; Humans ; Leukemia, Myeloid, Acute/diagnosis ; Male ; Middle Aged ; Prognosis ; Recurrence ; Retrospective Studies ; Survival Rate/trends ; Transplantation, Homologous/mortality ; Transplantation, Homologous/trends ; Treatment Outcome